Chiasma Inc.

2.85-0.0700-2.40%Vol 160.66K1Y Perf -34.84%
Apr 16th, 2021 10:05 DELAYED
BID2.84 ASK2.85
Open2.95 Previous Close2.92
Pre-Market- After-Market-
 - -%  - -
Target Price
13.60 
Analyst Rating
Strong Buy 1.00
Potential %
378.87 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/33/50 
Value Ranking
★★★+     54.30
Insiders Value % 3/6/12 mo.
-100/62/64 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/68/69 
Income Ranking
 —    -
Market Cap164.86M 
Earnings Rating
Buy
Price Range Ratio 52W %
1.61 
Earnings Date
6th May 2021

Today's Price Range

2.832.95

52W Range

2.777.75

5 Year PE Ratio Range

-2.60-1.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-2.99%
1 Month
-12.84%
3 Months
-25.51%
6 Months
-27.18%
1 Year
-34.84%
3 Years
104.20%
5 Years
-71.29%
10 Years
-

TickerPriceChg.Chg.%
CHMA2.85-0.0700-2.40
AAPL133.81-0.6900-0.51
GOOG2 294.13-2.5300-0.11
MSFT259.560.06000.02
XOM56.61-0.3700-0.65
WFC42.970.73001.73
JNJ161.010.62000.39
FB306.28-1.5400-0.50
GE13.48-0.0700-0.52
JPM153.891.72001.13
Financial StrengthValueIndustryS&P 500US Markets
8.10
9.20
0.02
0.00
-11.70
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
94.50
-44 793.00
-44 473.20
-
-
RevenueValueIndustryS&P 500US Markets
1.11M
0.02
-
-
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.35-0.328.57
Q03 2020-0.41-0.3026.83
Q02 2020-0.40-0.50-25.00
Q01 2020-0.31-0.36-16.13
Q04 2019-0.26-0.29-11.54
Q03 2019-0.21-0.204.76
Q02 2019-0.29-0.2513.79
Q01 2019-0.35-0.36-2.86
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.303.23Positive
6/2021 QR-0.30-7.14Negative
12/2021 FY-1.14-10.68Negative
12/2022 FY-0.66-53.49Negative
Next Report Date6th May 2021
Estimated EPS Next Report-0.30
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume160.66K
Shares Outstanding57.84M
Trades Count572
Dollar Volume5.80M
Avg. Volume1.65M
Avg. Weekly Volume587.07K
Avg. Monthly Volume1.78M
Avg. Quarterly Volume1.71M

Chiasma Inc. (NASDAQ: CHMA) stock closed at 2.92 per share at the end of the most recent trading day (a 0.34% change compared to the prior day closing price) with a volume of 892.14K shares and market capitalization of 164.86M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 48 people. Chiasma Inc. CEO is Raj Kannan.

The one-year performance of Chiasma Inc. stock is -34.84%, while year-to-date (YTD) performance is -32.87%. CHMA stock has a five-year performance of -71.29%. Its 52-week range is between 2.77 and 7.75, which gives CHMA stock a 52-week price range ratio of 1.61%

Chiasma Inc. currently has a PE ratio of -2.10, a price-to-book (PB) ratio of 1.90, a price-to-sale (PS) ratio of 147.49, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -52.67%, a ROC of -64.09% and a ROE of -80.77%. The company’s profit margin is -%, its EBITDA margin is -44 473.20%, and its revenue ttm is $1.11 Million , which makes it $0.02 revenue per share.

Of the last four earnings reports from Chiasma Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.30 for the next earnings report. Chiasma Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Chiasma Inc. is Strong Buy (1), with a target price of $13.6, which is +378.87% compared to the current price. The earnings rating for Chiasma Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Chiasma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Chiasma Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.27, ATR14 : 0.25, CCI20 : -74.01, Chaikin Money Flow : -0.10, MACD : -0.35, Money Flow Index : 42.66, ROC : -1.35, RSI : 28.66, STOCH (14,3) : 31.91, STOCH RSI : 1.00, UO : 39.40, Williams %R : -68.09), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Chiasma Inc. in the last 12-months were: David M. Stack (Buy at a value of $106 858), Raj Kannan (Buy at a value of $522 492), Roni Mamluk (Option Excercise at a value of $51 765), Roni Mamluk (Sold 27 981 shares of value $139 905 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Chiasma Inc.

Chiasma Inc is a biopharmaceutical company that focuses on improving the lives of patients who face challenges associated with existing treatments for their rare and debilitating diseases. Its product candidate includes octreotide capsule which has completed Phase III clinical trial and it is being developed for the potential treatment of acromegaly, a rare, debilitating disease. The company offers its products in the United States and the European Union.

CEO: Raj Kannan

Telephone: +1 617 928-5300

Address: 140 Kendrick Street, Needham 02494, MA, US

Number of employees: 48

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

52%48%

Bearish Bullish

56%44%

News

Stocktwits